Christina M. Dieli-Conwright, PhD, MPH, FACSM, CSCS

Assistant Professor of Research
Christina Dieli3

(323) 442-2905



Integrative Center for Oncology Research in Exercise

Mailing Address:

1540 Alcazar St., CHP 155 Los Angeles, CA 90089-9006

Current Research:



Professional Interests
Dr. Dieli-Conwright’s research is focused on: 1) Determining underlying physiologic mechanisms causing cancer treatment-related weight gain/lossin cancer patients; 2) Designing and executing exercise interventions to improve co-morbid disease outcomes (i.e., diabetes, cardiovascular disease) in cancer survivors; and 3) Disseminating effective lifestyle interventions to cancer survivors to alleviate the presence of co-morbid diseases to improve survivorship. In addition to cancer research, Dr. Dieli-Conwright is interested in the effects of estrogen on skeletal muscle hypertrophy mechanisms in women.Dr. Dieli-Conwright teaches coursework related to systems physiology, general pathophysiology, and skeletal muscle physiology.
  • California Polytechnic State University, San Luis Obispo, B.S.,Biological Sciences, 2002
  • California State University, Northridge, M.S., Kinesiology,2005
  • University of Southern California, Ph.D., Biokinesiology,2009
  • Beckman Research Institute, City of Hope, Postdoctoral Fellow,Cancer Etiology, 2011
Selected Publications
  • Dieli-Conwright CM, Ma H, Lacey JV, HendersonKD, Neuhausen S, Horn-Ross PL, Deapen D, Sullivan-Halley J,Bernstein L. Long-term and recent recreational physical activityand risk of endometrial cancer: the California Teachers Study, inreview, Cancer, Epidemiology, Biomarkers and Prevention.
  • Dieli-Conwright CM, Spektor T, Rice JC,Sattler FR, Schroeder ET. Hormone therapy and maximal eccentricexercise alters myostatin-related gene expression in postmenopausalwomen, in review, JSCR.
  • Schroeder ET, He J, Yarasheski KE, Binder EF, Castaneda-SceppaC, Bhasin S, Dieli-Conwright CM, Kawakubo M,Roubenoff R, Azen SP, Sattler FR. Value of measuring muscleperformance to assess changes in lean mass with testosterone andgrowth hormone supplementation. Eur J Appl Physiol 2011 Jul 12PMID: 21748366.
  • Dieli-Conwright CM, Sullivan-Halley J, PatelA, Press M, Malone K, Ursin G, Burkman R, Strom B, Simon M, WeissL, Marchbanks P, Folger S, Spirtas R, Deapen D, Bernstein L. DoesHormone Therapy Counter the Beneficial Effects of Physical Activityon Breast Cancer Risk in Postmenopausal Women? Cancer CausesControl 2011 Mar 22: 515-22; PMID: 21213036.
  • Emaus A, Degerstrøm J, Wilsgaard T, Hansen B,Dieli-Conwright CM, Furberg A, Pettersen S,Andersen L, Eggen A, Bernstein L, Thune I. Does avariation in self-reported physical activity reflect variation inobjectively measured physical activity, resting heart rate andphysical fitness? Results from the Tromsø Study. Scand J of PublicHealth 2010 Nov 38 (5 Suppl): 105-18; PMID: 21062845.
  • Dieli-Conwright CM, Spektor T, Rice JC,Sattler FR, Schroeder ET. Hormone Replacement Therapy and MessengerRNA Expression of Estrogen Coregulators After Exercise inPostmenopausal Women. Med Sci Sports Exerc 2010; 42:422-9.
  • Jensky NE, Sims JK, Dieli-Conwright CM, RiceJC, Sattler FR, Schroeder, ET. Exercise Does Not InfluenceMyostatin and Follistatin Messenger RNA Expression in Young Women.JSCR 2010; 24: 522-30.
  • Dieli-Conwright CM, Spektor T, Rice JC,Sattler FR, Schroeder ET. Hormone Replacement Therapy AttenuatesExercise-Induced Skeletal Muscle Damage in Postmenopausal Women JAppl Phys 2009; 107:803-8.
  • Dieli-Conwright CM, Spektor T, Rice JC,Sattler FR, Schroeder ET. Influence of Hormone Replacement Therapywith Maximal Eccentric Exercise on Myogenic Gene Expression inPostmenopausal Women. J Appl Phys 2009; 107(5):1381-1388.
  • Dieli-Conwright CM, Spektor T, Rice JC,Schroeder ET. Estrogen Receptor Coregulators inHuman Skeletal Muscle Cells: Alterations in Gene Expression byEstradiol Treatment. Acta Physiol 2009; 197:187-96.